Happenings

Mar 17, 2025
All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently includes Pfizer and BridgeBio and is…
Feb 25, 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day today in New York…
Feb 25, 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day today in New York…
Jun 18, 2024
Who: Alnylam Patient Education Liaison, Karen, joined by Ambassador, Jean, living with hATTR amyloidosis and Sonia Caraballo-Cartagena, MD Neuromuscular…
Apr 27, 2024
When: Saturday, April 27, 2024 AL will meet in the AM-Registration: 8:00-8:30AM ATTR will meet in the PM-Registration: 11:30-12:30PM Where: Goldberg Auditorium…
Apr 20, 2024
When: Saturday, April 20, 2024 AL will meet in the AM-Registration: 8:00-8:30AM ATTR will meet in the PM-Registration: 11:30-12:30PM Where: Rood Pavilion…
Apr 20, 2024
When: Saturday, April 20, 2024 AL will meet in the AM-Registration: 8:30-9:00AM ATTR will meet in the PM-Registration: 11:30-12:30PM Where: Reform Congregation…
Apr 20, 2024
If you are from Kansas, Nebraska, Missouri, Iowa, Arkansas, Oklahoma, or anywhere else, know you are welcome. When: Saturday, April 20, 2024 AL will meet in the…
Mar 01, 2024
"Light the Night for Amyloidosis" is an Amyloidosis Foundation awareness campaign created to draw attention to amyloidosis symptoms, diagnosis, treatment and…
Oct 21, 2023
When: Saturday, October 21st, 2023 9:00 am - 2:00 pm Where: Huntsman Cancer Hospital Salt Lake City, Utah In-Person and Virtual Registration Options Available…